Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2019 Sep 23;26(13):4423–4429. doi: 10.1245/s10434-019-07869-9

Table 1.

Clinicopathologic variables

Variable Median (range)
Age (years) 35.2 (3.4,72.3)
Follow up (years) 9.3 (3,31.5)
Gender (Female) 37 (56%)
Prophylactic intent 14 (21%)
Known Structural disease 10 (15%)
Tumor size (cm) 1.5 (0.1,7.5) cm
Node positive 36 (55%)
Number of positive nodes 1 (0,49)
Persistent biochemical disease* 36 (55%)
Preop calcitonin (pg/ml), n=41 636 (0,9600)
Preop CEA (ng/ml), n=17 29.4 (0.9,179)
Post op calcitonin (pg/ml), n=61 16 (0,9750)
Post op CEA (ng/ml), n=45 8.4 (0.8,1207)
*

Persistent biochemical disease was defined as an elevation in the first postoperative calcitonin level